CHAMGAP
MethodologyVerdictsExplanations (KO)Evidence CheckCitation KitMonitoring

Rocking bed × Sustained improvement in insomnia evidence checklist

Select a review item to see its details.
Required evidence, verification status and materials actually read
ItemAVerification statusBReading scopeCReview itemDCurrent findingsEWhy unverifiedFRequired materials and conditionsGFurther research
1 Partly verified Full text not readStored summary read N01 · Evidence conditionWhich exact insomnia question does this sheet cover?Required
The selected question is sustained improvement in insomnia. Preserve the subclaim's grade ? and note that people with insomnia or long-term use were not tested. Parent C54 concerns a one-night N3 measurement in healthy adults.
S01
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. There are no subclaim score, status, or assessment axes; do not fill them with parent values. Do not turn uncertainty into a new D, invalidity, or zero effect. The original content review remains incomplete.
Separation of the selected question, grade ?, and note from the parent C54 context
Keep the selected question, verdict record, and parent context separate. This is a proposal; no new investigation, calculation, or trial was performed.
2 Unverified Full text not readStored summary read N02 · Evidence conditionWas sustained improvement in people with insomnia actually tested?Required
The stored materials describe a crossover sleep-measurement study of 18 healthy young adults with one night per condition. The original text records that people with insomnia and long-term use were not tested.
S01
The currently required information remains unverified in the stored summary. This stored summary contains no direct patient trial or sustained clinical-improvement materials for the selected insomnia question. Do not describe absence of a new search as zero studies overall. The original content review remains incomplete.
Diagnosed insomnia population, clinical endpoints, and repeated or long-term follow-up
If direct materials are provided, connect them by population, endpoint, and duration. This is a proposal; no new investigation, calculation, or trial was performed.
3 Partly verified Full text not readStored summary read N03 · Evidence conditionWhat were the actual healthy sample and recruitment conditions?Required
The original scope of Perrault 2019 is 18 healthy young adults.
S01
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Specific ages, baseline sleep and insomnia symptoms, recruitment, and diagnostic and exclusion criteria are unverified. Do not reclassify the sample as patients. The original content review remains incomplete.
Age, health and sleep status, inclusion and exclusion, and baseline conditions
Retain differences between the healthy-population study and a clinical insomnia population. This is a proposal; no new investigation, calculation, or trial was performed.
4 Partly verified Full text not readStored summary read N04 · Evidence conditionWhat were the research device, exposure, and stationary comparison?Required
The original study involved one night each with a bed rocking laterally at 0.25 Hz and a stationary bed. Record original research conditions without creating device setup or use instructions.
S01
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Device and motor models, amplitude, actual operation and interruptions, matching environment and bedding, and equivalence to clinical products are unverified. The original content review remains incomplete.
Research bed rocking laterally at 0.25 Hz, stationary condition, and actual exposure
Distinguish the particular research device from other devices and exposures. This is a proposal; no new investigation, calculation, or trial was performed.
5 Partly verified Full text not readStored summary read N05 · Evidence conditionWhat was the design for crossover sequence, periods, and repeated observations?Required
The original account describes a randomized counterbalanced crossover trial in which 18 people spent one night in each condition.
S01
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Sequence generation and concealment, washout and adaptation nights, carryover and period effects, within-person modeling, and attrition are unverified. Do not count two nights as 36 people or two independent trials. The original content review remains incomplete.
Randomized counterbalancing, crossover sequence and washout, and within-person analysis
Connect the same person's conditions, nights, and repeated observations to the same trial. This is a proposal; no new investigation, calculation, or trial was performed.
6 Partly verified Full text not readStored summary read N06 · Evidence conditionWhich outcome does blinded sleep-stage scoring verify?Required
Preserve the original account that two scorers unaware of the condition scored sleep stages.
S01
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Clinical scales and function in people with insomnia, participant blinding, scoring agreement, missing records, and other assessment procedures are unverified. Do not inherit scorer blinding as a clinical insomnia effect. The original content review remains incomplete.
Polysomnography, scorer blinding, and differences from clinical symptoms
Distinguish strengths in physiological measurement from gaps in the clinical question. This is a proposal; no new investigation, calculation, or trial was performed.
7 Partly verified Full text not readStored summary read N07 · Evidence conditionWhat measure is N3 proportion, and does it represent improvement in insomnia?Required
The original endpoint is N3 as a proportion of total sleep. The original text records a one-night surrogate sleep measure, rather than a clinical outcome of having slept well.
S01
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Insomnia symptoms, remission, daytime function, quality of life, and sustained patient-reported outcomes are unverified. Do not replace them with a marker change. The original content review remains incomplete.
N3 relative to total sleep, sleep-measurement marker, and direct clinical endpoints
Separate the physiological marker from the patient-centered sustained-improvement question. This is a proposal; no new investigation, calculation, or trial was performed.
8 Partly verified Full text not readStored summary read N08 · Evidence conditionTo what scope do original N3 values, SEM, and adjusted P belong?Required
Preserve N3 27.41%±1.70 SEM versus 22.37%±1.65, Bonferroni-adjusted P=.0006, as original values for the one-night comparison in healthy adults.
S01
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. The 95% CI is a historical non-reporting account; exact within-person differences, denominators and missingness, and variance and model details are unverified. Do not calculate new differences, CIs, SDs, or insomnia effects. The original content review remains incomplete.
Condition-specific proportions, dispersion notation, timing, and original analysis
Distinguish proportions, SEM notation, and tests from the selected clinical question. This is a proposal; no new investigation, calculation, or trial was performed.
9 Partly verified Full text not readStored summary read N09 · Evidence conditionAre N2 onset and heart rate the same insomnia outcome?Required
N2 onset 10.08±1.54 versus 16.72±5.52 minutes, adjusted P=.006, and no heart-rate condition effect each have their own original context.
S01
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Dispersion types for the onset ± values, intervals, denominators, and clinical correspondence in people with insomnia are unverified. Do not turn N2 or heart rate into sustained insomnia improvement or safety certification. The original content review remains incomplete.
Other sleep physiology, timing, units, and attribution of non-significance
Connect N2, N3, heart rate, and clinical insomnia outcomes separately. This is a proposal; no new investigation, calculation, or trial was performed.
10 Partly verified Full text not readStored summary read N10 · Evidence conditionHow were the prespecified primary endpoint, Bonferroni adjustment, and selective reporting recorded?Required
The original text records that the original paper did not name a single prespecified primary endpoint and used Bonferroni adjustment.
S01
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Registration, plans, and original text have not been compared in this work. Prespecified definitions and tests of sustained insomnia improvement, and selective reporting, are also unverified. The original content review remains incomplete.
Primary and secondary hierarchy, multiplicity, registration, protocol, and SAP
Separate historical accounts from the scope of actual verification of prespecified plans. This is a proposal; no new investigation, calculation, or trial was performed.
11 Unverified Full text not readStored summary read N11 · Evidence conditionWhat were an important N3-change threshold and criteria for insomnia success?Required
The original text records no clinically important N3-increase threshold and non-reporting of a 95% CI.
S01
The currently required information remains unverified in the stored summary. Importance and success criteria and direct effects and intervals for sustained insomnia improvement are unverified. Do not substitute the marker P value for a clinical-importance threshold. The original content review remains incomplete.
Marker importance, clinical importance, intervals, and definitions of success
Connect materials that specify importance and analysis separately for the two outcomes. This is a proposal; no new investigation, calculation, or trial was performed.
12 Unverified Full text not readStored summary read N12 · Evidence conditionAre sustained effects, persistence after stopping, and repeated exposure known?Required
The original materials cover only one night per condition and explicitly state that the effect of continued use is unknown.
S01
The currently required information remains unverified in the stored summary. Repeated and long-term exposure, persistence after stopping, and clinical patient follow-up are unverified in these stored materials. Do not newly set a minimum required duration or dose. The original content review remains incomplete.
Continuous and long-term use, follow-up, cessation, and effect persistence
Separate a one-night signal from sustained improvement. This is a proposal; no new investigation, calculation, or trial was performed.
13 Unverified Full text not readStored summary read N13 · Evidence conditionWhat is known about concurrent exposures, environment, and other treatments?Required
There is an original account of a rocking versus stationary comparison in healthy adults.
S01
The currently required information remains unverified in the stored summary. Environment, sleep opportunity, caffeine, medication and other interventions, changes by group and period, and actual exposure are unverified. Do not write that there were no other differences. The original content review remains incomplete.
Shared sleep environment, medication and sleep interventions, actual use, and changes
Separate device exposure from other sleep conditions and interventions. This is a proposal; no new investigation, calculation, or trial was performed.
14 Unverified Full text not readStored summary read N14 · Evidence conditionWhat are the denominators, attrition, missingness, and selected clinical outcomes?Required
The preserved sample is 18 people with one night per condition.
S01
The currently required information remains unverified in the stored summary. Allocation, completion, endpoint-specific analysis counts, reasons for attrition and missingness, and detailed crossover handling are unverified. Do not repurpose these as clinical insomnia denominators or calculate new missingness. The original content review remains incomplete.
Allocation, observation, analysis, condition and endpoint losses, and handling
Distinguish the units of people, nights, outcomes, and models. This is a proposal; no new investigation, calculation, or trial was performed.
15 Unverified Full text not readStored summary read N15 · Evidence conditionIs the preserved registration wording an actual identifier?Required
The original registration wording is Not confirmed. Preserve the stored summary's wording and leave the actual registration identifier unrecorded.
S01
The currently required information remains unverified in the stored summary. This is not a new verification of non-registration or absence of registration or plans. Registration, protocol, and SAP remain unread externally. The original content review remains incomplete.
Registration-unconfirmed wording and actual plan and registration status
Record identity separately from unverified and access status. This is a proposal; no new investigation, calculation, or trial was performed.
16 Partly verified Full text not readStored summary read N16 · Evidence conditionWhat were the support and competing-interest declarations?Required
Preserve the original support from the Swiss National Science Foundation and University of Geneva and authors' declaration of no competing interests.
S01
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Itemized amounts, actual roles, individual employment, patents and declarations, and independent comparisons are unverified. Do not turn declarations into certification of independence. The original content review remains incomplete.
SNSF, University of Geneva, COI, roles, and actual verification
Separate the existence of support from declarations and actual verification levels. This is a proposal; no new investigation, calculation, or trial was performed.
17 Partly verified Full text not readStored summary read N17 · Evidence conditionDoes non-reporting of bed and motor provision or manufacturer involvement mean actual absence?Required
The original text records that free bed or motor provision and manufacturer involvement were not reported in the original paper.
S01
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. The complete original text has not been read in this work; actual absence, analysis, writing and publication support, and detailed relationships are unverified. The original content review remains incomplete.
Free product provision, manufacturer, analysis and writing, and author relationships
Distinguish non-reporting from certification of absence. This is a proposal; no new investigation, calculation, or trial was performed.
18 Partly verified Full text not readStored summary read N18 · Harm-information gaps supplementing the efficacy tableWhat can safety endpoints, adverse-event tables, and heart rate establish?Supplementary
The original text records no prespecified safety endpoints or adverse-event table and no condition effect on heart rate.
S01
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Systematic harms, event and exposure denominators, discontinuation, and long-term and vulnerable-group harms are unverified. Do not turn non-significant heart rate into overall device safety or safety in people with insomnia. The original content review remains incomplete.
Harm collection, denominators, duration, discontinuation, alternatives, and relatedness
Separate efficacy markers from safety and time scope. This is a proposal; no new investigation, calculation, or trial was performed.
19 Partly verified Full text not readStored summary read N19 · Evidence conditionAre the same 18 people, nights, and report being counted as independent replication?Required
Connect the context of 18 people, rocking and stationary nights, N3, N2, and heart rate in one Perrault 2019 report and crossover trial. This shares the same stored summary and trial with the other N3 subclaim.
S01
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Related and follow-up reports and external identity and independence comparisons have not been examined. Do not use original R1 and I2, two nights, or other endpoints as new totals of independent clinical trials or participants. The original content review remains incomplete.
Connections between reports, crossover trial, conditions, endpoints, and other subclaims
Distinguish undetermined unique clinical totals from numbers of report materials. This is a proposal; no new investigation, calculation, or trial was performed.
20 Unverified Full text not readStored summary read N20 · Evidence conditionIs the scope being extended to other populations, devices, treatment, or sustained improvement?Required
The original text records that claims should be limited to a one-night increase in a deep-sleep marker and should not be extended to insomnia or sustained effects.
S01
The currently required information remains unverified in the stored summary. Direct materials for patients, other devices and exposures, remission, function, and long-term results are unverified. Do not create device setup, sleep treatment, recommendations, or implementation instructions. The original content review remains incomplete.
Healthy-population signals, patients and other devices, clinical function, and sustained scope
Retain the boundary between a narrow marker study and the selected clinical gap. This is a proposal; no new investigation, calculation, or trial was performed.
21 Partly verified Full text not readStored summary read N21 · Evidence conditionWhat history do parent values, languages, dates, and empty corrections represent?Required
Preserve C54, Unknown safety, unrecorded original precision, false values, empty override reasons, Korean and English text, 2026-08-26, an empty correction array and deliberation string, historical cross-checks, and selected grade ? in the complete stored summary.
S01
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. This is not a current search, language or original-text review, correction or retraction verification, subclaim score, or new grade. The original content review remains incomplete.
C54, unrecorded, false, and empty assessment axes, Korean and English text, cross-checks, and corrections
Separate original records from production and correction events. This is a proposal; no new investigation, calculation, or trial was performed.
22 Partly verified Full text not readStored summary read N22 · Evidence conditionWhat are the actual summary-reading and external original-text and plan statuses?Required
The complete stored summary, one evidence entry, and one citation were read for production. Connect the original source link and label the summary Summary read and external materials Not read.
S01
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. External abstracts, full texts, registrations, protocols, SAPs, and disclosures remain unread, and access was not attempted. Do not inherit historical original-text accounts as current full-text reading or review. The original content review remains incomplete.
Material type, URL, acquisition, actual reading, and access history
Distinguish existence, acquisition, and reading level for each material. This is a proposal; no new investigation, calculation, or trial was performed.
No items match your search or filter.

22 itemsWhat the statuses mean

Assessment scope

Stored-material review date
Not recorded
Original evidence cut-off
2026-08-26
Scope actually checked
Existing review summaries and stored records of methodological application. Full papers, supplements, registrations, plans and original data were not read.
What the dates mean
This is the date the stored materials were checked, not the date of a new search of the clinical literature.
Population
The selected question concerns people with insomnia; the actual population in the original study was 18 healthy young adults
Ingredient, formulation and route
Original research bed rocking laterally at 0.25 Hz, one night per condition; device and exposure details unverified
Dose
Not recorded
Comparator
Stationary bed for the same participants; randomized counterbalanced crossover
Measured outcome
Direct material gap for sustained clinical improvement in insomnia; original N3, N2, and heart rate are separate physiological measures
Duration
One night per condition; repeated and long-term insomnia follow-up unverified
Questions outside this scope
Repurposing N3, N2, and heart rate from one night per condition in 18 healthy adults as sustained improvement, clinical function, or safety in people with insomnia; Calculating new differences, CIs, SDs, clinical effects, or response rates from N3 SEM, original P, or N2 ± values; Summing two nights, crossover conditions, other endpoints, or another N3 subclaim as new independent trials or participants; Changing historical non-reporting of a prespecified primary endpoint, 95% CI, and safety endpoints, or registration Not confirmed, into current original-text or plan reading or certification of absence; Changing parent C54, R1, I2, or a positive surrogate marker into a subclaim score or axes for selected grade ?, or new efficacy or safety grades; Summing the same people, groups, nights, timing, bibliography, registration, follow-up reports, or other subclaims as new independent trials, participants, or replications; Changing unreported harms, non-significant heart rate, public funding, competing-interest declarations, or unreported support and provision into zero events, overall safety, or certification of independence; Changing original registration Not confirmed or Not applicable, or funding wording for a delivery system, into actual registration identifiers, supporting institutions, or a current verification of absence; Filling absent subclaim scores, statuses, or assessment axes with parent values, or inheriting historical cross-checks as current review or external reading; New calculations, hypothetical numbers, new effects or CIs, reassessment, independence certification, or instructions for sleep treatment, devices, rehabilitation, return to work, exercise, or treatment implementation

Evidence and sources

The links below lead to the sources. A link alone does not mean the original source was read or its latest publication status verified.

S01 · Perrault AA et al. 2019

PubMed

Material type
Randomized counterbalanced crossover sleep trial
Materials actually read
Summary read; external material unread
Findings recorded in the stored summary
The selected original note records that people with insomnia or long-term use were not tested. N3 27.41%±1.70 SEM versus 22.37%±1.65, adjusted P=.0006; N2 onset 10.08±1.54 versus 16.72±5.52 minutes, P=.006; and no heart-rate condition effect belong to a separate physiological context in healthy adults. Do not create new insomnia effects, differences, CIs, or sustained-effect or safety certification.
Record level
Outcome wording in the stored summary
Study overlap and independent replication
Perrault 2019 is a randomized counterbalanced crossover report in which 18 healthy young adults spent one night each with a bed rocking laterally at 0.25 Hz and a stationary bed. N3, N2, and heart rate are different physiological outcomes for the same people, conditions, and nights; this is not a direct clinical trial in people with insomnia or of long-term use. It shares the same stored summary and trial with the other N3 subclaim; do not sum two nights or repeated observations as new participants or independent trials. Report and material counts are not totals of unique clinical trials, participants, or independent replications; undetermined totals remain unrecorded. Do not retroactively turn original replication and independence axes or historical accounts into current identity or independence certification.
Public availability, access and reading status by material
MaterialPublic availabilityAccess statusActually readNotes
Stored summaryStored fileStored summarySummary readOnly the stored JSON summary and bibliography were used for production. This does not constitute external verification or completed content review.
External paperPublic availability unverified; only bibliography links preservedUnread; access not attemptedNot readNo external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status.
Registration materialPublic availability unverified; only bibliography links preservedUnread; access not attemptedNot readNo external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status.
ProtocolPublic availability unverified; only bibliography links preservedUnread; access not attemptedNot readNo external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status.
Statistical analysis planPublic availability unverified; only bibliography links preservedUnread; access not attemptedNot readNo external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status.
Funding, product-support and COI materialPublic availability unverified; only bibliography links preservedUnread; access not attemptedNot readNo external access or click testing was performed in the original preparation. URLs or registration identifiers alone do not upgrade acquisition/reading status.

Report counts versus independent study counts

Perrault 2019 is a randomized counterbalanced crossover report in which 18 healthy young adults spent one night each with a bed rocking laterally at 0.25 Hz and a stationary bed. N3, N2, and heart rate are different physiological outcomes for the same people, conditions, and nights; this is not a direct clinical trial in people with insomnia or of long-term use. It shares the same stored summary and trial with the other N3 subclaim; do not sum two nights or repeated observations as new participants or independent trials. Report and material counts are not totals of unique clinical trials, participants, or independent replications; undetermined totals remain unrecorded. Do not retroactively turn original replication and independence axes or historical accounts into current identity or independence certification.

Review criteria

Version 1.0 · Criteria record date 2026-10-06. These are Chamgap's own application conditions, informed by the referenced methods. They do not constitute official assessment-tool certification or a new efficacy score.

N01 · Which exact insomnia question does this sheet cover?
Required materials and conditions
Separation of the selected question, grade ?, and note from the parent C54 context
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Separation of the selected question, grade ?, and note from the parent C54 context. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Separation of the selected question, grade ?, and note from the parent C54 context
Referenced methods
M03 §3.1, §3.2.1–3.2.4 question-clarification principles; detailed separation rules are internally designed; M04 §4.5, §4.6.3; limits of this material conversion follow the review scope and internal design
N02 · Was sustained improvement in people with insomnia actually tested?
Required materials and conditions
Diagnosed insomnia population, clinical endpoints, and repeated or long-term follow-up
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Diagnosed insomnia population, clinical endpoints, and repeated or long-term follow-up. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Diagnosed insomnia population, clinical endpoints, and repeated or long-term follow-up
Referenced methods
M03 §3.2.1; detailed population criteria are a Chamgap design; M03 §3.2.1–3.2.4; dose, persistence, and effect-modification details are Chamgap designs; M03 §3.2.4; Chamgap's own extrapolation boundary
N03 · What were the actual healthy sample and recruitment conditions?
Required materials and conditions
Age, health and sleep status, inclusion and exclusion, and baseline conditions
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Age, health and sleep status, inclusion and exclusion, and baseline conditions. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Age, health and sleep status, inclusion and exclusion, and baseline conditions
Referenced methods
M03 §3.2.1; detailed population conditions are Chamgap's own design
N04 · What were the research device, exposure, and stationary comparison?
Required materials and conditions
Research bed rocking laterally at 0.25 Hz, stationary condition, and actual exposure
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Research bed rocking laterally at 0.25 Hz, stationary condition, and actual exposure. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Research bed rocking laterally at 0.25 Hz, stationary condition, and actual exposure
Referenced methods
M03 §3.2.2–3.2.3; Reverse-direction labels and assessment adaptation are Chamgap design; M03 §3.2.3 and M08 §8.2.2–8.2.3; Chamgap application
N05 · What was the design for crossover sequence, periods, and repeated observations?
Required materials and conditions
Randomized counterbalancing, crossover sequence and washout, and within-person analysis
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Randomized counterbalancing, crossover sequence and washout, and within-person analysis. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Randomized counterbalancing, crossover sequence and washout, and within-person analysis
Referenced methods
M08 §8.1–8.2.3; Chamgap adaptation; M08 §8.2.2, M15 §15.3.1; Chamgap adaptation; M04 §4.6.1–4.6.2 on distinguishing studies from reports; cohort and outcome connections are Chamgap adaptations
N06 · Which outcome does blinded sleep-stage scoring verify?
Required materials and conditions
Polysomnography, scorer blinding, and differences from clinical symptoms
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Polysomnography, scorer blinding, and differences from clinical symptoms. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Polysomnography, scorer blinding, and differences from clinical symptoms
Referenced methods
M08 Table 8.2.a, M03 §3.2.4; Chamgap adaptation; M03 §3.2.4; Chamgap's own extrapolation boundary
N07 · What measure is N3 proportion, and does it represent improvement in insomnia?
Required materials and conditions
N3 relative to total sleep, sleep-measurement marker, and direct clinical endpoints
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: N3 relative to total sleep, sleep-measurement marker, and direct clinical endpoints. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: N3 relative to total sleep, sleep-measurement marker, and direct clinical endpoints
Referenced methods
M03 §3.2.4, M15 §15.3.1–15.3.3; question-specific outcome adaptations are Chamgap's own design; M03 §3.2.4; Chamgap's own limits on extension
N08 · To what scope do original N3 values, SEM, and adjusted P belong?
Required materials and conditions
Condition-specific proportions, dispersion notation, timing, and original analysis
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Condition-specific proportions, dispersion notation, timing, and original analysis. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Condition-specific proportions, dispersion notation, timing, and original analysis
Referenced methods
M03 §3.2.4, M15 §15.3.1–15.3.3; question-specific outcome adaptations are internally designed; M08 Table 8.2.a, M15 §15.3, M19 §19.1.2–19.2.4; design-specific adaptations are internally designed; M08 §8.2.2, M15 §15.3.1; internal application; M15 §15.3.1–15.3.3; internal application
N09 · Are N2 onset and heart rate the same insomnia outcome?
Required materials and conditions
Other sleep physiology, timing, units, and attribution of non-significance
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Other sleep physiology, timing, units, and attribution of non-significance. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Other sleep physiology, timing, units, and attribution of non-significance
Referenced methods
M03 §3.2.4, M15 §15.3.1–15.3.3; question-specific outcome adaptations are Chamgap designs; M04 §4.6.3, M15 §15.3.1–15.3.3; status separation is a Chamgap design; M03 §3.2.4; Chamgap's own extrapolation boundary
N10 · How were the prespecified primary endpoint, Bonferroni adjustment, and selective reporting recorded?
Required materials and conditions
Primary and secondary hierarchy, multiplicity, registration, protocol, and SAP
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Primary and secondary hierarchy, multiplicity, registration, protocol, and SAP. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Primary and secondary hierarchy, multiplicity, registration, protocol, and SAP
Referenced methods
M08 Table 8.2.a, M04 §4.6.3; Chamgap application; M04 §4.5, §4.6.3; limits to this material conversion reflect the review scope and Chamgap's own design
N11 · What were an important N3-change threshold and criteria for insomnia success?
Required materials and conditions
Marker importance, clinical importance, intervals, and definitions of success
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Marker importance, clinical importance, intervals, and definitions of success. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Marker importance, clinical importance, intervals, and definitions of success
Referenced methods
M15 §15.3.1–15.3.3; Chamgap's own application; M03 §3.2.4; Chamgap's own limits on extension
N12 · Are sustained effects, persistence after stopping, and repeated exposure known?
Required materials and conditions
Continuous and long-term use, follow-up, cessation, and effect persistence
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Continuous and long-term use, follow-up, cessation, and effect persistence. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Continuous and long-term use, follow-up, cessation, and effect persistence
Referenced methods
M03 §3.2.1–3.2.4; dose, persistence, and effect-modification details are Chamgap designs; M03 §3.2.4, M15 §15.3.1–15.3.3; question-specific outcome adaptations are Chamgap designs
N13 · What is known about concurrent exposures, environment, and other treatments?
Required materials and conditions
Shared sleep environment, medication and sleep interventions, actual use, and changes
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Shared sleep environment, medication and sleep interventions, actual use, and changes. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Shared sleep environment, medication and sleep interventions, actual use, and changes
Referenced methods
M03 §3.2.3, M08 §8.2.2–8.2.3; Chamgap adaptation
N14 · What are the denominators, attrition, missingness, and selected clinical outcomes?
Required materials and conditions
Allocation, observation, analysis, condition and endpoint losses, and handling
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Allocation, observation, analysis, condition and endpoint losses, and handling. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Allocation, observation, analysis, condition and endpoint losses, and handling
Referenced methods
M08 Table 8.2.a, M15 §15.3 and M19 §19.1.2–19.2.4; Design-specific adaptation is Chamgap design; M08 §8.2.2 and M15 §15.3.1; Chamgap application
N15 · Is the preserved registration wording an actual identifier?
Required materials and conditions
Registration-unconfirmed wording and actual plan and registration status
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Registration-unconfirmed wording and actual plan and registration status. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Registration-unconfirmed wording and actual plan and registration status
Referenced methods
M08 Table 8.2.a, M04 §4.6.3; Chamgap application; M04 §4.5–4.6 principles for collecting and selecting materials; separation of access and reading and hyperlink rules are Chamgap's own design
N16 · What were the support and competing-interest declarations?
Required materials and conditions
SNSF, University of Geneva, COI, roles, and actual verification
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: SNSF, University of Geneva, COI, roles, and actual verification. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: SNSF, University of Geneva, COI, roles, and actual verification
Referenced methods
Chamgap's own conditions for independence and attribution. The official methodological sections used in this example do not validate every detail of these items.
N17 · Does non-reporting of bed and motor provision or manufacturer involvement mean actual absence?
Required materials and conditions
Free product provision, manufacturer, analysis and writing, and author relationships
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Free product provision, manufacturer, analysis and writing, and author relationships. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Free product provision, manufacturer, analysis and writing, and author relationships
Referenced methods
Chamgap's own conditions for independence and attribution. The official methodological sections used in this example do not validate every detail of these items.
N18 · What can safety endpoints, adverse-event tables, and heart rate establish?
Required materials and conditions
Harm collection, denominators, duration, discontinuation, alternatives, and relatedness
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Harm collection, denominators, duration, discontinuation, alternatives, and relatedness. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Supplementary
Application exceptions
Address gaps in safety materials for the selected subclaim. Do not judge safety from N3/heart rate, absence days, or parent safety wording, or create new harm incidence or instructions for sleep treatment, devices, or rehabilitation.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Harm collection, denominators, duration, discontinuation, alternatives, and relatedness
Referenced methods
M19 §19.1.2–19.2.4; Chamgap's own application; M19 §19.1.2–19.2.4; detailed distinctions are Chamgap's own design; M19 §19.1.2–19.2.4; Chamgap's own application; M19 §19.1.2–19.2.4, M04 §4.6.3; Chamgap's own application; M19 §19.1.2–19.2.4; Chamgap's own application; Chamgap's own interpretive boundary. M19 principles are referenced; no official causality tool was run
N19 · Are the same 18 people, nights, and report being counted as independent replication?
Required materials and conditions
Connections between reports, crossover trial, conditions, endpoints, and other subclaims
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Connections between reports, crossover trial, conditions, endpoints, and other subclaims. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Connections between reports, crossover trial, conditions, endpoints, and other subclaims
Referenced methods
Study/report distinction in M04 §4.6.1–4.6.2; Cohort/outcome linkage is Chamgap application; M04 §4.6.1–4.6.2 and M15 §15.3.1; Chamgap application
N20 · Is the scope being extended to other populations, devices, treatment, or sustained improvement?
Required materials and conditions
Healthy-population signals, patients and other devices, clinical function, and sustained scope
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Healthy-population signals, patients and other devices, clinical function, and sustained scope. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Healthy-population signals, patients and other devices, clinical function, and sustained scope
Referenced methods
M03 §3.2.1–3.2.4; dose, persistence and effect-modification details are Chamgap's own design; M03 §3.2.4; Chamgap extension boundaries
N21 · What history do parent values, languages, dates, and empty corrections represent?
Required materials and conditions
C54, unrecorded, false, and empty assessment axes, Korean and English text, cross-checks, and corrections
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: C54, unrecorded, false, and empty assessment axes, Korean and English text, cross-checks, and corrections. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: C54, unrecorded, false, and empty assessment axes, Korean and English text, cross-checks, and corrections
Referenced methods
M04 §4.5, §4.6.3; current material-conversion limits reflect review scope and our own design; M04 §4.6.3, M15 §15.3.1–15.3.3; status distinctions are our own design
N22 · What are the actual summary-reading and external original-text and plan statuses?
Required materials and conditions
Material type, URL, acquisition, actual reading, and access history
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Material type, URL, acquisition, actual reading, and access history. This work connects preserved wording; the original content review remains incomplete.
Requirement and applicability
Required
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Material type, URL, acquisition, actual reading, and access history
Referenced methods
M04 §4.5–4.6 material collection/selection principles; acquisition/reading separation and hyperlink specifications are internally designed; M04 §4.5, §4.6.3; limits of this material conversion follow the review scope and internal design
Referenced methods and the sections actually reviewed

M03 · Cochrane Handbook 6.5 (2024), chapter updated 2023-08

Official methodology · §3.1, §3.2.1–3.2.3, MECIR C5/C7/C13

Referenced principle
Clearly record the question, eligibility conditions and reasons for changes, and distinguish variations in interventions.
Extent of review
Preserved method HTML copies; no current method-content re-review or official tool execution

M04 · Cochrane Handbook 6.5.1 (2025), chapter updated 2025-03

Official methodology · §4.5, §4.6.1–4.6.3, MECIR C42

Referenced principle
Distinguish studies from reports and link them; do not omit a study solely because results are unreported.
Extent of review
Preserved method HTML copies; no current method-content re-review or official tool execution

M08 · Cochrane Handbook 6.5 (2024), chapter updated 2019-10

Official methodology · §8.1–8.2.3, Table 8.2.a

Referenced principle
Define the outcome and effect of interest, then examine randomization, deviations, missing data, measurement and selective reporting.
Extent of review
Preserved method HTML copies; no current method-content re-review or official tool execution

M15 · Cochrane Handbook 6.5 (2024), chapter updated 2023-08

Official methodology · §15.2.4, §15.3.1–15.3.3

Referenced principle
Distinguish effect estimates, intervals, importance and applicability. Sample size alone does not determine precision.
Extent of review
Preserved method HTML copies; no current method-content re-review or official tool execution

M19 · Cochrane Handbook 6.5 (2024), chapter updated 2019-10

Official methodology · §19.1.2, §19.2.1–19.2.4

Referenced principle
Harm questions may require different designs, populations and follow-up from efficacy questions. Case reports do not establish incidence rates.
Extent of review
Preserved method HTML copies; no current method-content re-review or official tool execution
What the statuses mean
Met
Status for necessary evidence confirmed after existing content review. No completion is declared in the current presentation.
Partly verified
Some information in the stored summary is linked into the table. External comparison/content review is not complete.
Unverified
The article leaves this unverified, or required material is absent from the current stored summary. This is distinct from zero, absence or safety.
Review incomplete
Existing content review remains incomplete.
Not reported
Not reported within the stored material actually read; not extended to the entire primary paper.
Inaccessible
Means an actual access failure. Access not attempted here is not assigned this state.
Not applicable
Not used as a substitute for an evidence gap.
Conflicting data
Requires an observed disagreement under the same comparison criteria; not automatically judged in this production.
Insufficient evidence for the conditions
Marks a gap in additional material required by the selected conditions; not a new efficacy grade.

Change history

2026-10-11 · Public page/material version 1.0

Reader pages and materials were prepared from the existing 22 items. No new clinical search, change in verification status or scoring was performed.

The stored-material review date (Not recorded) and original evidence cut-off (2026-08-26) were retained unchanged.

Researcher downloads

These materials provide the same evidence, scope and verification status as this page.

View all item details

N01 · Which exact insomnia question does this sheet cover?

Current findings
The selected question is sustained improvement in insomnia. Preserve the subclaim's grade ? and note that people with insomnia or long-term use were not tested. Parent C54 concerns a one-night N3 measurement in healthy adults.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. There are no subclaim score, status, or assessment axes; do not fill them with parent values. Do not turn uncertainty into a new D, invalidity, or zero effect. The original content review remains incomplete.
Reason for missing information
There are no subclaim score, status, or assessment axes; do not fill them with parent values. Do not turn uncertainty into a new D, invalidity, or zero effect.
Required materials and conditions
Separation of the selected question, grade ?, and note from the parent C54 context
Materials to obtain first
Correction records for the selected claim and parent assessment
Further research
Keep the selected question, verdict record, and parent context separate. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Separation of the selected question, grade ?, and note from the parent C54 context. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Separation of the selected question, grade ?, and note from the parent C54 context
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.1, §3.2.1–3.2.4 question-clarification principles; detailed separation rules are internally designed; M04 §4.5, §4.6.3; limits of this material conversion follow the review scope and internal design

Related sources S01

N02 · Was sustained improvement in people with insomnia actually tested?

Current findings
The stored materials describe a crossover sleep-measurement study of 18 healthy young adults with one night per condition. The original text records that people with insomnia and long-term use were not tested.
Verification status
Unverified
Materials actually read
Summary read; external material unread
Why unverified
The currently required information remains unverified in the stored summary. This stored summary contains no direct patient trial or sustained clinical-improvement materials for the selected insomnia question. Do not describe absence of a new search as zero studies overall. The original content review remains incomplete.
Reason for missing information
This stored summary contains no direct patient trial or sustained clinical-improvement materials for the selected insomnia question. Do not describe absence of a new search as zero studies overall.
Required materials and conditions
Diagnosed insomnia population, clinical endpoints, and repeated or long-term follow-up
Materials to obtain first
Direct clinical and follow-up materials in an insomnia population
Further research
If direct materials are provided, connect them by population, endpoint, and duration. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Diagnosed insomnia population, clinical endpoints, and repeated or long-term follow-up. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Diagnosed insomnia population, clinical endpoints, and repeated or long-term follow-up
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.2.1; detailed population criteria are a Chamgap design; M03 §3.2.1–3.2.4; dose, persistence, and effect-modification details are Chamgap designs; M03 §3.2.4; Chamgap's own extrapolation boundary

Related sources S01

N03 · What were the actual healthy sample and recruitment conditions?

Current findings
The original scope of Perrault 2019 is 18 healthy young adults.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Specific ages, baseline sleep and insomnia symptoms, recruitment, and diagnostic and exclusion criteria are unverified. Do not reclassify the sample as patients. The original content review remains incomplete.
Reason for missing information
Specific ages, baseline sleep and insomnia symptoms, recruitment, and diagnostic and exclusion criteria are unverified. Do not reclassify the sample as patients.
Required materials and conditions
Age, health and sleep status, inclusion and exclusion, and baseline conditions
Materials to obtain first
Recruitment and baseline sleep-characteristic tables
Further research
Retain differences between the healthy-population study and a clinical insomnia population. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Age, health and sleep status, inclusion and exclusion, and baseline conditions. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Age, health and sleep status, inclusion and exclusion, and baseline conditions
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.2.1; detailed population conditions are Chamgap's own design

Related sources S01

N04 · What were the research device, exposure, and stationary comparison?

Current findings
The original study involved one night each with a bed rocking laterally at 0.25 Hz and a stationary bed. Record original research conditions without creating device setup or use instructions.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Device and motor models, amplitude, actual operation and interruptions, matching environment and bedding, and equivalence to clinical products are unverified. The original content review remains incomplete.
Reason for missing information
Device and motor models, amplitude, actual operation and interruptions, matching environment and bedding, and equivalence to clinical products are unverified.
Required materials and conditions
Research bed rocking laterally at 0.25 Hz, stationary condition, and actual exposure
Materials to obtain first
Device specifications and condition and actual-exposure records
Further research
Distinguish the particular research device from other devices and exposures. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Research bed rocking laterally at 0.25 Hz, stationary condition, and actual exposure. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Research bed rocking laterally at 0.25 Hz, stationary condition, and actual exposure
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.2.2–3.2.3; Reverse-direction labels and assessment adaptation are Chamgap design; M03 §3.2.3 and M08 §8.2.2–8.2.3; Chamgap application

Related sources S01

N05 · What was the design for crossover sequence, periods, and repeated observations?

Current findings
The original account describes a randomized counterbalanced crossover trial in which 18 people spent one night in each condition.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Sequence generation and concealment, washout and adaptation nights, carryover and period effects, within-person modeling, and attrition are unverified. Do not count two nights as 36 people or two independent trials. The original content review remains incomplete.
Reason for missing information
Sequence generation and concealment, washout and adaptation nights, carryover and period effects, within-person modeling, and attrition are unverified. Do not count two nights as 36 people or two independent trials.
Required materials and conditions
Randomized counterbalancing, crossover sequence and washout, and within-person analysis
Materials to obtain first
Crossover schedule, sequence, analysis, and flow diagram
Further research
Connect the same person's conditions, nights, and repeated observations to the same trial. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Randomized counterbalancing, crossover sequence and washout, and within-person analysis. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Randomized counterbalancing, crossover sequence and washout, and within-person analysis
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M08 §8.1–8.2.3; Chamgap adaptation; M08 §8.2.2, M15 §15.3.1; Chamgap adaptation; M04 §4.6.1–4.6.2 on distinguishing studies from reports; cohort and outcome connections are Chamgap adaptations

Related sources S01

N06 · Which outcome does blinded sleep-stage scoring verify?

Current findings
Preserve the original account that two scorers unaware of the condition scored sleep stages.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Clinical scales and function in people with insomnia, participant blinding, scoring agreement, missing records, and other assessment procedures are unverified. Do not inherit scorer blinding as a clinical insomnia effect. The original content review remains incomplete.
Reason for missing information
Clinical scales and function in people with insomnia, participant blinding, scoring agreement, missing records, and other assessment procedures are unverified. Do not inherit scorer blinding as a clinical insomnia effect.
Required materials and conditions
Polysomnography, scorer blinding, and differences from clinical symptoms
Materials to obtain first
Scoring and measurement procedures and direct clinical results
Further research
Distinguish strengths in physiological measurement from gaps in the clinical question. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Polysomnography, scorer blinding, and differences from clinical symptoms. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Polysomnography, scorer blinding, and differences from clinical symptoms
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M08 Table 8.2.a, M03 §3.2.4; Chamgap adaptation; M03 §3.2.4; Chamgap's own extrapolation boundary

Related sources S01

N07 · What measure is N3 proportion, and does it represent improvement in insomnia?

Current findings
The original endpoint is N3 as a proportion of total sleep. The original text records a one-night surrogate sleep measure, rather than a clinical outcome of having slept well.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Insomnia symptoms, remission, daytime function, quality of life, and sustained patient-reported outcomes are unverified. Do not replace them with a marker change. The original content review remains incomplete.
Reason for missing information
Insomnia symptoms, remission, daytime function, quality of life, and sustained patient-reported outcomes are unverified. Do not replace them with a marker change.
Required materials and conditions
N3 relative to total sleep, sleep-measurement marker, and direct clinical endpoints
Materials to obtain first
Marker definitions and direct clinical endpoint materials for insomnia
Further research
Separate the physiological marker from the patient-centered sustained-improvement question. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: N3 relative to total sleep, sleep-measurement marker, and direct clinical endpoints. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: N3 relative to total sleep, sleep-measurement marker, and direct clinical endpoints
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.2.4, M15 §15.3.1–15.3.3; question-specific outcome adaptations are Chamgap's own design; M03 §3.2.4; Chamgap's own limits on extension

Related sources S01

N08 · To what scope do original N3 values, SEM, and adjusted P belong?

Current findings
Preserve N3 27.41%±1.70 SEM versus 22.37%±1.65, Bonferroni-adjusted P=.0006, as original values for the one-night comparison in healthy adults.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. The 95% CI is a historical non-reporting account; exact within-person differences, denominators and missingness, and variance and model details are unverified. Do not calculate new differences, CIs, SDs, or insomnia effects. The original content review remains incomplete.
Reason for missing information
The 95% CI is a historical non-reporting account; exact within-person differences, denominators and missingness, and variance and model details are unverified. Do not calculate new differences, CIs, SDs, or insomnia effects.
Required materials and conditions
Condition-specific proportions, dispersion notation, timing, and original analysis
Materials to obtain first
Original N3 results and crossover-model tables
Further research
Distinguish proportions, SEM notation, and tests from the selected clinical question. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Condition-specific proportions, dispersion notation, timing, and original analysis. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Condition-specific proportions, dispersion notation, timing, and original analysis
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.2.4, M15 §15.3.1–15.3.3; question-specific outcome adaptations are internally designed; M08 Table 8.2.a, M15 §15.3, M19 §19.1.2–19.2.4; design-specific adaptations are internally designed; M08 §8.2.2, M15 §15.3.1; internal application; M15 §15.3.1–15.3.3; internal application

Related sources S01

N09 · Are N2 onset and heart rate the same insomnia outcome?

Current findings
N2 onset 10.08±1.54 versus 16.72±5.52 minutes, adjusted P=.006, and no heart-rate condition effect each have their own original context.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Dispersion types for the onset ± values, intervals, denominators, and clinical correspondence in people with insomnia are unverified. Do not turn N2 or heart rate into sustained insomnia improvement or safety certification. The original content review remains incomplete.
Reason for missing information
Dispersion types for the onset ± values, intervals, denominators, and clinical correspondence in people with insomnia are unverified. Do not turn N2 or heart rate into sustained insomnia improvement or safety certification.
Required materials and conditions
Other sleep physiology, timing, units, and attribution of non-significance
Materials to obtain first
Other outcome tables and measurement and analysis definitions
Further research
Connect N2, N3, heart rate, and clinical insomnia outcomes separately. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Other sleep physiology, timing, units, and attribution of non-significance. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Other sleep physiology, timing, units, and attribution of non-significance
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.2.4, M15 §15.3.1–15.3.3; question-specific outcome adaptations are Chamgap designs; M04 §4.6.3, M15 §15.3.1–15.3.3; status separation is a Chamgap design; M03 §3.2.4; Chamgap's own extrapolation boundary

Related sources S01

N10 · How were the prespecified primary endpoint, Bonferroni adjustment, and selective reporting recorded?

Current findings
The original text records that the original paper did not name a single prespecified primary endpoint and used Bonferroni adjustment.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Registration, plans, and original text have not been compared in this work. Prespecified definitions and tests of sustained insomnia improvement, and selective reporting, are also unverified. The original content review remains incomplete.
Reason for missing information
Registration, plans, and original text have not been compared in this work. Prespecified definitions and tests of sustained insomnia improvement, and selective reporting, are also unverified.
Required materials and conditions
Primary and secondary hierarchy, multiplicity, registration, protocol, and SAP
Materials to obtain first
Protocol, SAP, registration, and change history
Further research
Separate historical accounts from the scope of actual verification of prespecified plans. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Primary and secondary hierarchy, multiplicity, registration, protocol, and SAP. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Primary and secondary hierarchy, multiplicity, registration, protocol, and SAP
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M08 Table 8.2.a, M04 §4.6.3; Chamgap application; M04 §4.5, §4.6.3; limits to this material conversion reflect the review scope and Chamgap's own design

Related sources S01

N11 · What were an important N3-change threshold and criteria for insomnia success?

Current findings
The original text records no clinically important N3-increase threshold and non-reporting of a 95% CI.
Verification status
Unverified
Materials actually read
Summary read; external material unread
Why unverified
The currently required information remains unverified in the stored summary. Importance and success criteria and direct effects and intervals for sustained insomnia improvement are unverified. Do not substitute the marker P value for a clinical-importance threshold. The original content review remains incomplete.
Reason for missing information
Importance and success criteria and direct effects and intervals for sustained insomnia improvement are unverified. Do not substitute the marker P value for a clinical-importance threshold.
Required materials and conditions
Marker importance, clinical importance, intervals, and definitions of success
Materials to obtain first
Evidence on N3 importance and direct insomnia analyses and criteria
Further research
Connect materials that specify importance and analysis separately for the two outcomes. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Marker importance, clinical importance, intervals, and definitions of success. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Marker importance, clinical importance, intervals, and definitions of success
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M15 §15.3.1–15.3.3; Chamgap's own application; M03 §3.2.4; Chamgap's own limits on extension

Related sources S01

N12 · Are sustained effects, persistence after stopping, and repeated exposure known?

Current findings
The original materials cover only one night per condition and explicitly state that the effect of continued use is unknown.
Verification status
Unverified
Materials actually read
Summary read; external material unread
Why unverified
The currently required information remains unverified in the stored summary. Repeated and long-term exposure, persistence after stopping, and clinical patient follow-up are unverified in these stored materials. Do not newly set a minimum required duration or dose. The original content review remains incomplete.
Reason for missing information
Repeated and long-term exposure, persistence after stopping, and clinical patient follow-up are unverified in these stored materials. Do not newly set a minimum required duration or dose.
Required materials and conditions
Continuous and long-term use, follow-up, cessation, and effect persistence
Materials to obtain first
Direct long-term and post-cessation follow-up materials
Further research
Separate a one-night signal from sustained improvement. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Continuous and long-term use, follow-up, cessation, and effect persistence. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Continuous and long-term use, follow-up, cessation, and effect persistence
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.2.1–3.2.4; dose, persistence, and effect-modification details are Chamgap designs; M03 §3.2.4, M15 §15.3.1–15.3.3; question-specific outcome adaptations are Chamgap designs

Related sources S01

N13 · What is known about concurrent exposures, environment, and other treatments?

Current findings
There is an original account of a rocking versus stationary comparison in healthy adults.
Verification status
Unverified
Materials actually read
Summary read; external material unread
Why unverified
The currently required information remains unverified in the stored summary. Environment, sleep opportunity, caffeine, medication and other interventions, changes by group and period, and actual exposure are unverified. Do not write that there were no other differences. The original content review remains incomplete.
Reason for missing information
Environment, sleep opportunity, caffeine, medication and other interventions, changes by group and period, and actual exposure are unverified. Do not write that there were no other differences.
Required materials and conditions
Shared sleep environment, medication and sleep interventions, actual use, and changes
Materials to obtain first
Condition-specific environment, concurrent-intervention, and exposure records
Further research
Separate device exposure from other sleep conditions and interventions. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Shared sleep environment, medication and sleep interventions, actual use, and changes. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Shared sleep environment, medication and sleep interventions, actual use, and changes
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.2.3, M08 §8.2.2–8.2.3; Chamgap adaptation

Related sources S01

N14 · What are the denominators, attrition, missingness, and selected clinical outcomes?

Current findings
The preserved sample is 18 people with one night per condition.
Verification status
Unverified
Materials actually read
Summary read; external material unread
Why unverified
The currently required information remains unverified in the stored summary. Allocation, completion, endpoint-specific analysis counts, reasons for attrition and missingness, and detailed crossover handling are unverified. Do not repurpose these as clinical insomnia denominators or calculate new missingness. The original content review remains incomplete.
Reason for missing information
Allocation, completion, endpoint-specific analysis counts, reasons for attrition and missingness, and detailed crossover handling are unverified. Do not repurpose these as clinical insomnia denominators or calculate new missingness.
Required materials and conditions
Allocation, observation, analysis, condition and endpoint losses, and handling
Materials to obtain first
Flow diagrams and denominators by condition and outcome
Further research
Distinguish the units of people, nights, outcomes, and models. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Allocation, observation, analysis, condition and endpoint losses, and handling. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Allocation, observation, analysis, condition and endpoint losses, and handling
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M08 Table 8.2.a, M15 §15.3 and M19 §19.1.2–19.2.4; Design-specific adaptation is Chamgap design; M08 §8.2.2 and M15 §15.3.1; Chamgap application

Related sources S01

N15 · Is the preserved registration wording an actual identifier?

Current findings
The original registration wording is Not confirmed. Preserve the stored summary's wording and leave the actual registration identifier unrecorded.
Verification status
Unverified
Materials actually read
Summary read; external material unread
Why unverified
The currently required information remains unverified in the stored summary. This is not a new verification of non-registration or absence of registration or plans. Registration, protocol, and SAP remain unread externally. The original content review remains incomplete.
Reason for missing information
This is not a new verification of non-registration or absence of registration or plans. Registration, protocol, and SAP remain unread externally.
Required materials and conditions
Registration-unconfirmed wording and actual plan and registration status
Materials to obtain first
Actual registration identity, protocol, and SAP
Further research
Record identity separately from unverified and access status. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Registration-unconfirmed wording and actual plan and registration status. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Registration-unconfirmed wording and actual plan and registration status
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M08 Table 8.2.a, M04 §4.6.3; Chamgap application; M04 §4.5–4.6 principles for collecting and selecting materials; separation of access and reading and hyperlink rules are Chamgap's own design

Related sources S01

N16 · What were the support and competing-interest declarations?

Current findings
Preserve the original support from the Swiss National Science Foundation and University of Geneva and authors' declaration of no competing interests.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Itemized amounts, actual roles, individual employment, patents and declarations, and independent comparisons are unverified. Do not turn declarations into certification of independence. The original content review remains incomplete.
Reason for missing information
Itemized amounts, actual roles, individual employment, patents and declarations, and independent comparisons are unverified. Do not turn declarations into certification of independence.
Required materials and conditions
SNSF, University of Geneva, COI, roles, and actual verification
Materials to obtain first
Support, author and COI disclosures, and role statements
Further research
Separate the existence of support from declarations and actual verification levels. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: SNSF, University of Geneva, COI, roles, and actual verification. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: SNSF, University of Geneva, COI, roles, and actual verification
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
Chamgap's own conditions for independence and attribution. The official methodological sections used in this example do not validate every detail of these items.

Related sources S01

N17 · Does non-reporting of bed and motor provision or manufacturer involvement mean actual absence?

Current findings
The original text records that free bed or motor provision and manufacturer involvement were not reported in the original paper.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. The complete original text has not been read in this work; actual absence, analysis, writing and publication support, and detailed relationships are unverified. The original content review remains incomplete.
Reason for missing information
The complete original text has not been read in this work; actual absence, analysis, writing and publication support, and detailed relationships are unverified.
Required materials and conditions
Free product provision, manufacturer, analysis and writing, and author relationships
Materials to obtain first
Product and manufacturer, analysis and writing, and COI disclosures
Further research
Distinguish non-reporting from certification of absence. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Free product provision, manufacturer, analysis and writing, and author relationships. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Free product provision, manufacturer, analysis and writing, and author relationships
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
Chamgap's own conditions for independence and attribution. The official methodological sections used in this example do not validate every detail of these items.

Related sources S01

N18 · What can safety endpoints, adverse-event tables, and heart rate establish?

Current findings
The original text records no prespecified safety endpoints or adverse-event table and no condition effect on heart rate.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Systematic harms, event and exposure denominators, discontinuation, and long-term and vulnerable-group harms are unverified. Do not turn non-significant heart rate into overall device safety or safety in people with insomnia. The original content review remains incomplete.
Reason for missing information
Systematic harms, event and exposure denominators, discontinuation, and long-term and vulnerable-group harms are unverified. Do not turn non-significant heart rate into overall device safety or safety in people with insomnia.
Required materials and conditions
Harm collection, denominators, duration, discontinuation, alternatives, and relatedness
Materials to obtain first
Safety collection, event and discontinuation, and long-term materials
Further research
Separate efficacy markers from safety and time scope. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Harm collection, denominators, duration, discontinuation, alternatives, and relatedness. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Harm collection, denominators, duration, discontinuation, alternatives, and relatedness
Application exceptions
Address gaps in safety materials for the selected subclaim. Do not judge safety from N3/heart rate, absence days, or parent safety wording, or create new harm incidence or instructions for sleep treatment, devices, or rehabilitation.
Referenced methods
M19 §19.1.2–19.2.4; Chamgap's own application; M19 §19.1.2–19.2.4; detailed distinctions are Chamgap's own design; M19 §19.1.2–19.2.4; Chamgap's own application; M19 §19.1.2–19.2.4, M04 §4.6.3; Chamgap's own application; M19 §19.1.2–19.2.4; Chamgap's own application; Chamgap's own interpretive boundary. M19 principles are referenced; no official causality tool was run

Related sources S01

N19 · Are the same 18 people, nights, and report being counted as independent replication?

Current findings
Connect the context of 18 people, rocking and stationary nights, N3, N2, and heart rate in one Perrault 2019 report and crossover trial. This shares the same stored summary and trial with the other N3 subclaim.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. Related and follow-up reports and external identity and independence comparisons have not been examined. Do not use original R1 and I2, two nights, or other endpoints as new totals of independent clinical trials or participants. The original content review remains incomplete.
Reason for missing information
Related and follow-up reports and external identity and independence comparisons have not been examined. Do not use original R1 and I2, two nights, or other endpoints as new totals of independent clinical trials or participants.
Required materials and conditions
Connections between reports, crossover trial, conditions, endpoints, and other subclaims
Materials to obtain first
Registration and related and follow-up report connections
Further research
Distinguish undetermined unique clinical totals from numbers of report materials. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Connections between reports, crossover trial, conditions, endpoints, and other subclaims. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Connections between reports, crossover trial, conditions, endpoints, and other subclaims
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
Study/report distinction in M04 §4.6.1–4.6.2; Cohort/outcome linkage is Chamgap application; M04 §4.6.1–4.6.2 and M15 §15.3.1; Chamgap application

Related sources S01

N20 · Is the scope being extended to other populations, devices, treatment, or sustained improvement?

Current findings
The original text records that claims should be limited to a one-night increase in a deep-sleep marker and should not be extended to insomnia or sustained effects.
Verification status
Unverified
Materials actually read
Summary read; external material unread
Why unverified
The currently required information remains unverified in the stored summary. Direct materials for patients, other devices and exposures, remission, function, and long-term results are unverified. Do not create device setup, sleep treatment, recommendations, or implementation instructions. The original content review remains incomplete.
Reason for missing information
Direct materials for patients, other devices and exposures, remission, function, and long-term results are unverified. Do not create device setup, sleep treatment, recommendations, or implementation instructions.
Required materials and conditions
Healthy-population signals, patients and other devices, clinical function, and sustained scope
Materials to obtain first
Separate population and device materials and sustained clinical results
Further research
Retain the boundary between a narrow marker study and the selected clinical gap. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Healthy-population signals, patients and other devices, clinical function, and sustained scope. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Healthy-population signals, patients and other devices, clinical function, and sustained scope
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M03 §3.2.1–3.2.4; dose, persistence and effect-modification details are Chamgap's own design; M03 §3.2.4; Chamgap extension boundaries

Related sources S01

N21 · What history do parent values, languages, dates, and empty corrections represent?

Current findings
Preserve C54, Unknown safety, unrecorded original precision, false values, empty override reasons, Korean and English text, 2026-08-26, an empty correction array and deliberation string, historical cross-checks, and selected grade ? in the complete stored summary.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. This is not a current search, language or original-text review, correction or retraction verification, subclaim score, or new grade. The original content review remains incomplete.
Reason for missing information
This is not a current search, language or original-text review, correction or retraction verification, subclaim score, or new grade.
Required materials and conditions
C54, unrecorded, false, and empty assessment axes, Korean and English text, cross-checks, and corrections
Materials to obtain first
New corrections, user feedback, and provided materials
Further research
Separate original records from production and correction events. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: C54, unrecorded, false, and empty assessment axes, Korean and English text, cross-checks, and corrections. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: C54, unrecorded, false, and empty assessment axes, Korean and English text, cross-checks, and corrections
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M04 §4.5, §4.6.3; current material-conversion limits reflect review scope and our own design; M04 §4.6.3, M15 §15.3.1–15.3.3; status distinctions are our own design

Related sources S01

N22 · What are the actual summary-reading and external original-text and plan statuses?

Current findings
The complete stored summary, one evidence entry, and one citation were read for production. Connect the original source link and label the summary Summary read and external materials Not read.
Verification status
Partly verified
Materials actually read
Summary read; external material unread
Why unverified
Only the relevant information from the stored summary is recorded; detailed original materials remain unread and the original content review is incomplete. External abstracts, full texts, registrations, protocols, SAPs, and disclosures remain unread, and access was not attempted. Do not inherit historical original-text accounts as current full-text reading or review. The original content review remains incomplete.
Reason for missing information
External abstracts, full texts, registrations, protocols, SAPs, and disclosures remain unread, and access was not attempted. Do not inherit historical original-text accounts as current full-text reading or review.
Required materials and conditions
Material type, URL, acquisition, actual reading, and access history
Materials to obtain first
Each original material and actual reading history
Further research
Distinguish existence, acquisition, and reading level for each material. This is a proposal; no new investigation, calculation, or trial was performed.
Remaining uncertainty
This record links preserved-summary statements; it does not establish external-paper comparison, a new efficacy verdict or completed content review.
Conditions for verification
Relevant original materials and analysis scope must be provided, and unverified matters must be distinguishable: Material type, URL, acquisition, actual reading, and access history. This work connects preserved wording; the original content review remains incomplete.
Why this condition is needed
A production item connecting required and currently available materials for the selected question by distinguishing: Material type, URL, acquisition, actual reading, and access history
Application exceptions
Limited to the stored summary for the selected formulation, population, endpoint and period. It does not substitute for numbers from other formulations/trials/endpoints or unread external material.
Referenced methods
M04 §4.5–4.6 material collection/selection principles; acquisition/reading separation and hyperlink specifications are internally designed; M04 §4.5, §4.6.3; limits of this material conversion follow the review scope and internal design

Related sources S01